H.R. 3290 118th Congress
340B Transparency Act
- Health
- Sponsor: Rep. Bucshon, Larry [R-IN-8]
- Congress.gov ↗
Latest action, Nov 20, 2024: Placed on the Union Calendar, Calendar No. 628.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
Sponsor
Sponsored by Rep. Bucshon, Larry [R-IN-8] (Republican). No cosponsors.
Referred to: House: Energy and Commerce Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
7 reports
340B HEALTH
RAY ANDERSON
7 reports
7 reports
AMERICAN HOSPITAL ASSOCIATION
O'NEILL, ATHY & CASEY, P.C.
7 reports
AMGEN USA INC.
MARSHALL & POPP, LLC
7 reports
ASSOCIATION OF AMERICAN MEDICAL COLLEGES
RUBIN HEALTH POLICY CONSULTING, LLC
7 reports
7 reports
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC.
THE MCMANUS GROUP
7 reports
GENENTECH
THE MCMANUS GROUP
7 reports
GENENTECH
CAPITOL COUNSEL LLC
7 reports
GENENTECH, INC.
MARSHALL & POPP, LLC
7 reports
7 reports
All 25 of 72 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| 340B HEALTH | 7 | $2.2M | Q4 2023 | Q3 2024 | yes | |
| 340B HEALTH | RAY ANDERSON | 7 | $60K | Q4 2023 | Q3 2024 | — |
| AMERICA'S ESSENTIAL HOSPITALS | 7 | $3.4M | Q4 2023 | Q3 2024 | yes | |
| AMERICAN HOSPITAL ASSOCIATION | O'NEILL, ATHY & CASEY, P.C. | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| AMGEN USA INC. | MARSHALL & POPP, LLC | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 7 | $4.5M | Q4 2023 | Q3 2024 | yes | |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | RUBIN HEALTH POLICY CONSULTING, LLC | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| CALIFORNIA HOSPITAL ASSOCIATION | 7 | $2.7M | Q4 2023 | Q3 2024 | yes | |
| CATHOLIC HEALTH ASSOCIATION OF THE UNITED STATES | 7 | $1.3M | Q4 2023 | Q3 2024 | yes | |
| DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. | THE MCMANUS GROUP | 7 | $440K | Q4 2023 | Q3 2024 | yes |
| GENENTECH | THE MCMANUS GROUP | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| GENENTECH | CAPITOL COUNSEL LLC | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| GENENTECH, INC. | MARSHALL & POPP, LLC | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| GSK (FKA GLAXOSMITHKLINE INC.) | 7 | $8.2M | Q4 2023 | Q3 2024 | yes | |
| HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA | 7 | $493K | Q4 2023 | Q3 2024 | yes | |
| INDIANA UNIVERSITY HEALTH INC | 7 | $790K | Q4 2023 | Q3 2024 | yes | |
| INDIANA UNIVERSITY HEALTH INC | DEBORAH HOHLT | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| LARGE UROLOGY GROUP PRACTICE ASSOCIATION | THE MCMANUS GROUP | 7 | $630K | Q4 2023 | Q3 2024 | yes |
| MASS GENERAL BRIGHAM | O'NEILL, ATHY & CASEY, P.C. | 7 | $400K | Q4 2023 | Q3 2024 | yes |
| MERCK & CO INC | 7 | $16.2M | Q4 2023 | Q3 2024 | yes | |
| NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.) | NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES | 7 | $11.8M | Q4 2023 | Q3 2024 | yes |
| NATIONWIDE CHILDREN'S HOSPITAL INC | 7 | $375K | Q4 2023 | Q3 2024 | yes | |
| PFIZER, INC. | MARSHALL & POPP, LLC | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 7 | $50.1M | Q4 2023 | Q3 2024 | yes | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | THE MCMANUS GROUP | 7 | $0 | Q4 2023 | Q3 2024 | yes |